Cargando…

Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives

In 2008 the Ludwig Boltzmann Cluster Oncology (LBC ONC) was established on the basis of two previous Ludwig Boltzmann Institutes working in the field of hematology and cancer research. The general aim of the LBC ONC is to improve treatment of hematopoietic neoplasms by eradicating cancer-initiating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valent, Peter, Hadzijusufovic, Emir, Grunt, Thomas, Karlic, Heidrun, Peter, Barbara, Herrmann, Harald, Eisenwort, Gregor, Hoermann, Gregor, Schulenburg, Axel, Willmann, Michael, Hubmann, Rainer, Shehata, Medhat, Selzer, Edgar, Gleixner, Karoline V., Rülicke, Thomas, Sperr, Wolfgang R., Marian, Brigitte, Pfeilstöcker, Michael, Pehamberger, Hubert, Keil, Felix, Jäger, Ulrich, Zielinski, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132878/ https://www.ncbi.nlm.nih.gov/pubmed/30006759 http://dx.doi.org/10.1007/s00508-018-1355-7

Ejemplares similares

Engraftment in NSG(SCF) mice correlates with the WHO category and prognosis in systemic mastocytosis
por: Willmann, Michael, et al.
Publicado: (2023)

Ludwig Boltzmann : a cien años de su muerte /
Publicado: (2007)

Leben und Werk Ludwig Boltzmanns
por: Flamm, D
Publicado: (1994)

Ludwig Boltzmann: Mensch, Physiker, Philosoph
por: Broda, Engelbert
Publicado: (1955)

Ludwig Boltzmann: man, physicist, philosopher
por: Broda, Engelbert
Publicado: (1983)

Ludwig Boltzmann and his influence on science
por: Flamm, D
Publicado: (1981)

Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML
por: Valent, Peter, et al.
Publicado: (2019)

Ludwig Boltzmann: The Man Who Trusted Atoms
por: Cercignani, Carlo
Publicado: (1998)

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis
por: Schneeweiss, Mathias, et al.
Publicado: (2018)

TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML
por: Valent, Peter, et al.
Publicado: (2017)

Identification of a Leukemia-Initiating Stem Cell in Human Mast Cell Leukemia
por: Eisenwort, Gregor, et al.
Publicado: (2019)

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells
por: Peter, Barbara, et al.
Publicado: (2017)

International Symposium : Festschrift Boltzmann (Ludwig) on his 150th Birthday
Publicado: (1994)

Atoms, mechanics, and probability: Ludwig Boltzmann's statistico-mechanical writings : an exegesis
por: Darrigol, Olivier
Publicado: (2018)

BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph(+) chronic myeloid leukemia
por: Peter, Barbara, et al.
Publicado: (2022)

Identification of bromodomain-containing protein 4 (BRD4) as a novel marker and epigenetic target in mast cell leukemia
por: Wedeh, Ghaith, et al.
Publicado: (2015)

Phenotypic Characterization of Leukemia-Initiating Stem Cells in Chronic Myelomonocytic Leukemia
por: Eisenwort, Gregor, et al.
Publicado: (2021)

CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1(T315I)+ clones in TKI-resistant CML
por: Schneeweiss-Gleixner, Mathias, et al.
Publicado: (2019)

In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells
por: Gamperl, Susanne, et al.
Publicado: (2020)

Phenotyping and Target Expression Profiling of CD34(+)/CD38(−) and CD34(+)/CD38(+) Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
por: Blatt, Katharina, et al.
Publicado: (2018)

Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site
por: Hadzijusufovic, Emir, et al.
Publicado: (2017)

Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms
por: Willmann, Michael, et al.
Publicado: (2018)

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V(+) Neoplastic Mast Cells
por: Schneeweiss-Gleixner, Mathias, et al.
Publicado: (2022)

Incidence of symptomatic Covid‐19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population
por: Graf, Irene, et al.
Publicado: (2022)

FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H()
por: Valent, Peter, et al.
Publicado: (2013)

Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis
por: Greiner, Georg, et al.
Publicado: (2020)

Jozef Stefan Ludwig Boltzmann e l'energia radiante: momenti culturali per la didattica
por: Marcolini, Lorenzo
Publicado: (1997)

Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal
por: Willmann, Michael, et al.
Publicado: (2021)

The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cells
por: Stefanzl, Gabriele, et al.
Publicado: (2017)

Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells
por: Gamperl, Susanne, et al.
Publicado: (2019)

Should Liquid Based Cytology (LBC) be Applied to Thyroid Fine Needle Aspiration Cytology Samples?: Comparative Analysis of Conventional and LBC Smears
por: Mahajan, Swati, et al.
Publicado: (2021)

Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML
por: Valent, Peter, et al.
Publicado: (2019)

Replication of sialodacryoadenitis virus of rat in LBC cell culture
por: Hirano, N., et al.
Publicado: (1986)

Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia
por: Cerny-Reiterer, Sabine, et al.
Publicado: (2014)

Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond
por: Sprinzl, Bettina, et al.
Publicado: (2021)

Cell‐based and antibody‐mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues
por: Valent, Peter, et al.
Publicado: (2020)

Phenotyping of Human Melanoma Cells Reveals a Unique Composition of Receptor Targets and a Subpopulation Co-Expressing ErbB4, EPO-R and NGF-R
por: Mirkina, Irina, et al.
Publicado: (2014)

Replication of rat coronavirus in a rat cell line, LBC
por: Hirano, N., et al.
Publicado: (1985)

NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation
por: Hadzijusufovic, E, et al.
Publicado: (2012)

Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells
por: Karlic, Heidrun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8fru7rep2r6gk1hfavccfi06bl